title: Commentary on "Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease." A Canadian perspective.
abstract: The criteria for mild cognitive impairment due to Alzheimer's disease (AD) and preclinical AD, while offering great hope of fostering research on primary and secondary prevention for AD, are currently unsuitable for use in general clinical practice and must be used with great caution in specialized memory clinics.
authors.affiliation: McGill Center for Studies in Aging, McGill University, Montreal, Quebec, Canada. serge.gauthier@mcill.ca
authors.forename: Serge
authors.initials: S
authors.lastname: Gauthier
authors.forename: Christopher
authors.initials: C
authors.lastname: Patterson
authors.forename: Michael
authors.initials: M
authors.lastname: Gordon
authors.forename: Jean-Paul
authors.initials: JP
authors.lastname: Soucy
authors.forename: François
authors.initials: F
authors.lastname: Schubert
authors.forename: Antoine
authors.initials: A
authors.lastname: Leuzy
mesh_terms: D032722:Advance Care Planning / Q000941:ethics / Q000592:standards*; D000544:Alzheimer Disease / Q000175:diagnosis* / Q000453:epidemiology / Q000517:prevention & control; D003072:Cognition Disorders / Q000175:diagnosis* / Q000453:epidemiology / Q000517:prevention & control; D042241:Early Diagnosis; D006801:Humans; D008569:Memory Disorders / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control; D010044:Outpatient Clinics, Hospital / Q000639:trends; D017410:Practice Guidelines as Topic / Q000592:standards*; D011792:Quebec / Q000453:epidemiology